USMD Holdings, Inc. 4
4 · USMD Holdings, Inc. · Filed Jan 6, 2016
Insider Transaction Report
Form 4
Saalfield James G.
Director
Transactions
- Other
Common Stock ($.01 par)
2015-12-31$108.72/sh+13$1,413→ 122,526 total(indirect: Indirectly held through UANT Ventures, L.P.) - Other
Options to Purchase
2015-12-31−69→ 1,706 total(indirect: Indiectly held through UANT Ventures, L.P.)Exercise: $24.84From: 2012-08-31Exp: 2017-08-31→ Common Stock ($.01 par) (1,706 underlying) - Other
Common Stock ($.01 par)
2015-12-31−3,934→ 118,592 total(indirect: Indirectly held through UANT Ventures, L.P.)
Holdings
- 17,103
Common Stock ($.01 par)
- 13,248(indirect: Held in James G. Saalfield, MD, P.A.)
Common Stock ($.01 par)
Footnotes (2)
- [F1]UANT Ventures, LP ("Ventures") reallocated certain of its partnership interests among its partners based upon the results of a capital call. Dr. Saalfield received additional partnership interests as a result of this reallocation, which resulted in an increase in his indirect beneficial ownership of the shares of the issuer's common stock held by Ventures.
- [F2]Ventures issued partnership interests to certain individuals and the issuance of these interests was dilutive to the ownership of Ventures held by certain of the existing partners, including Dr. Saalfield. This reduction in Dr. Saalfield's ownership of Ventures resulted in a corresponding decrease in his indirect beneficial ownership of shares and options to purchase shares of the issuer's common stock held by Ventures. No consideration was paid and Dr. Saalfield did not receive any consideration as a result of the transaction.